Is low-dose hormone replacement therapy for postmenopausal women efficacious and desirable?

By Lobo R. A.   Whitehead M. I.  

Climacteric, Vol. 4, Iss. 2, 2001-06 ,pp. : 110-119

Informa Healthcare

Access to resources Recommend Favorite

The long-term effects of low-dose 17β-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study

By Kaya C.   Cengiz S. Dincer   Cengiz B.   Akgun G.  

Climacteric, Vol. 9, Iss. 6, 2006-12 ,pp. : 437-445

Informa Healthcare

Access to resources Recommend Favorite

Differing effects of low-dose estrogen–progestin therapy and pravastatin in postmenopausal hypercholesterolemic women

By Davis S. R.   Goldstat R.   Newman A.   Berry K.   Burger H. G.   Meredith I.   Koch K.  

Climacteric, Vol. 5, Iss. 4, 2002-12 ,pp. : 341-350

Informa Healthcare

Access to resources Recommend Favorite

Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogen - a pilot study

By O'Neill S. M.   Eden J.   Baber R.   Ekangaki A.   Stocks J. M.   Wolthers T.   Davis S. R.  

Climacteric, Vol. 6, Iss. 4, 2003-12 ,pp. : 347-353

Informa Healthcare

Access to resources Recommend Favorite

Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet

By Weisberg E   Ayton R   Darling G   Farrell E   Murkies A   O'Neill S   Kirkegard Y   Fraser IS  

Climacteric, Vol. 8, Iss. 1, 2005-03 ,pp. : 83-93

Informa Healthcare

Access to resources Recommend Favorite